Benjamin Taton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin Taton has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Bertrand Chauveau
Department of Pathology, Bordeaux University Hospital, Bordeaux, France
2 shared publications - Lionel Couzi
Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France
2 shared publications Nicolas Grenier
CHU de Bordeaux, Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Hôpital Pellegrin, France
2 shared publicationsPierre Merville
Service de Néphrologie, Transplantation, Dialyse et Aphérèses, CHU de Bordeaux , Bordeaux , France
2 shared publications- Pierre Pfirmann
CHU de Bordeaux, service de néphrologie-transplantation-dialyse-aphérèses, hôpital Pellegrin, 33000 Bordeaux, France
2 shared publications Thierry Colin
Sophia Genetics, Cité de la Photonique, Pessac, F-33600, France
2 shared publications
Latest Publications
- 4 September 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 39 (4) , 627-636
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017
While opportunistic infections are a frequent and challenging problem in kidney transplant recipients, their long-term epidemiology remains hardly known. Opportunistic infections were recorded in 1144 recipients transplanted in our center between 2004 and 2015. Incidence rates and baseline risk factors were determined using joint frailty models. After a median follow-up of 5.6 years, 544 opportunistic infections occurred in 373/1144 (33%) patients, dominated by viral infections (396/544, 72%), especially CMV syndromes and diseases (213/544, 39%). A third of the infected patients experienced at least 2 opportunistic infections. The incidence of opportunistic infections was 10 times higher during the first year post-transplantation than afterwards (34.7 infections for 100 patient-years vs. 3.64). Opportunistic infections associated with the age of the donor (p = 0.032), the age of the recipient (p = 0.049), the CMV serostatus (p < 10−6), a higher class II HLA mismatch (p = 0.032), and an induction treatment including rabbit anti-thymocyte globulins (p = 0.026). Repeated opportunistic infections associated with each other (p < 10−6) and with renal death (p < 10−6). Opportunistic infections occur with a 2-period incidence pattern and many susceptible patients suffer from repeated episodes. This knowledge may help tailor new prevention and follow-up strategies to reduce the burden of opportunistic infections and their impact on transplantation outcome.
- 4 September 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 39 (4) , 627-636
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017
While opportunistic infections are a frequent and challenging problem in kidney transplant recipients, their long-term epidemiology remains hardly known. Opportunistic infections were recorded in 1144 recipients transplanted in our center between 2004 and 2015. Incidence rates and baseline risk factors were determined using joint frailty models. After a median follow-up of 5.6 years, 544 opportunistic infections occurred in 373/1144 (33%) patients, dominated by viral infections (396/544, 72%), especially CMV syndromes and diseases (213/544, 39%). A third of the infected patients experienced at least 2 opportunistic infections. The incidence of opportunistic infections was 10 times higher during the first year post-transplantation than afterwards (34.7 infections for 100 patient-years vs. 3.64). Opportunistic infections associated with the age of the donor (p = 0.032), the age of the recipient (p = 0.049), the CMV serostatus (p < 10−6), a higher class II HLA mismatch (p = 0.032), and an induction treatment including rabbit anti-thymocyte globulins (p = 0.026). Repeated opportunistic infections associated with each other (p < 10−6) and with renal death (p < 10−6). Opportunistic infections occur with a 2-period incidence pattern and many susceptible patients suffer from repeated episodes. This knowledge may help tailor new prevention and follow-up strategies to reduce the burden of opportunistic infections and their impact on transplantation outcome.
- Open Access
- 16 June 2023
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (9) , e1341-e1342
A Patient with Lymphadenopathy, Hypercalcemia, and Kidney Injury
An abstract is unavailable. This article is available as a PDF only.
- 16 June 2023
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (9) , e1341-e1342
Open AccessA Patient with Lymphadenopathy, Hypercalcemia, and Kidney Injury
An abstract is unavailable. This article is available as a PDF only.
- 7 September 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (11) , 1924-1933
Magnetic Resonance Elastography as Surrogate Marker of Interstitial Fibrosis in Kidney Transplantation: A Prospective Study
Key Points: Magnetic resonance elastography–derived stiffness does not directly reflect the extent of fibrosis in kidney transplantation. Mean magnetic resonance elastography–derived stiffness displays high interpatient variability, even in allografts without significant fibrosis, suggesting a strong influence of confounding factors. Background: Fibrosis progression is a major prognosis factor in kidney transplantation. Its assessment requires an allograft biopsy, which remains an invasive procedure at risk of complications. Methods: We assessed renal stiffness by magnetic resonance elastography (MRE) as a surrogate marker of fibrosis in a prospective cohort of kidney transplant recipients compared with the histologic gold standard. Interstitial fibrosis was evaluated by three methods: the semi-quantitative Banff ci score, a visual quantitative evaluation by a pathologist, and a computer-assisted quantitative evaluation. MRE-derived stiffness was assessed at the superior, median, and inferior poles of the allograft. Results: We initially enrolled 73 patients, but only 55 had measurements of their allograft stiffness by MRE before an allograft biopsy. There was no significant correlation between MRE-derived stiffness at the biopsy site and the ci score (ρ=–0.25, P=0.06) or with the two quantitative assessments (pathologist: ρ=–0.25, P=0.07; computer assisted: ρ=–0.21, P=0.12). We observed negative correlations between the stiffness of both the biopsy site and the whole allograft, with either the glomerulosclerosis percentage (ρ=–0.32, P=0.02 and ρ=–0.31, P=0.02, respectively) and the overall nephron fibrosis percentage, defined as the mean of the percentages of glomerulosclerosis and interstitial fibrosis (ρ=–0.30, P=0.02 and ρ=–0.28, P=0.04, respectively). At patient level, mean MRE-derived stiffness was similar across the three poles of the allograft (±0.25 kPa). However, a high variability of mean stiffness was found between patients, suggesting a strong influence of confounding factors. Finally, no significant correlation was found between mean MRE-derived stiffness and the slope of eGFR (P=0.08). Conclusions: MRE-derived stiffness does not directly reflect the extent of fibrosis in kidney transplantation.
- 7 September 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (11) , 1924-1933
Magnetic Resonance Elastography as Surrogate Marker of Interstitial Fibrosis in Kidney Transplantation: A Prospective Study
Key Points: Magnetic resonance elastography–derived stiffness does not directly reflect the extent of fibrosis in kidney transplantation. Mean magnetic resonance elastography–derived stiffness displays high interpatient variability, even in allografts without significant fibrosis, suggesting a strong influence of confounding factors. Background: Fibrosis progression is a major prognosis factor in kidney transplantation. Its assessment requires an allograft biopsy, which remains an invasive procedure at risk of complications. Methods: We assessed renal stiffness by magnetic resonance elastography (MRE) as a surrogate marker of fibrosis in a prospective cohort of kidney transplant recipients compared with the histologic gold standard. Interstitial fibrosis was evaluated by three methods: the semi-quantitative Banff ci score, a visual quantitative evaluation by a pathologist, and a computer-assisted quantitative evaluation. MRE-derived stiffness was assessed at the superior, median, and inferior poles of the allograft. Results: We initially enrolled 73 patients, but only 55 had measurements of their allograft stiffness by MRE before an allograft biopsy. There was no significant correlation between MRE-derived stiffness at the biopsy site and the ci score (ρ=–0.25, P=0.06) or with the two quantitative assessments (pathologist: ρ=–0.25, P=0.07; computer assisted: ρ=–0.21, P=0.12). We observed negative correlations between the stiffness of both the biopsy site and the whole allograft, with either the glomerulosclerosis percentage (ρ=–0.32, P=0.02 and ρ=–0.31, P=0.02, respectively) and the overall nephron fibrosis percentage, defined as the mean of the percentages of glomerulosclerosis and interstitial fibrosis (ρ=–0.30, P=0.02 and ρ=–0.28, P=0.04, respectively). At patient level, mean MRE-derived stiffness was similar across the three poles of the allograft (±0.25 kPa). However, a high variability of mean stiffness was found between patients, suggesting a strong influence of confounding factors. Finally, no significant correlation was found between mean MRE-derived stiffness and the slope of eGFR (P=0.08). Conclusions: MRE-derived stiffness does not directly reflect the extent of fibrosis in kidney transplantation.
- Open Access
- 1 April 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9) , 1734-1735
Commentary on “Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study”
An abstract is unavailable. This article is available as a PDF only.
- 1 April 2022
- Published by Wolters Kluwer Health in Transplantation
- Vol. 106 (9) , 1734-1735
Open AccessCommentary on “Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study”
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 27 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 648
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
Background: Early diagnosis of thrombotic thrombocytopenic purpura (TTP) versus hemolytic and uremic syndrome (HUS) is critical for the prompt initiation of specific therapies. Objective: To evaluate the diagnostic performance of the proteinuria/creatininuria ratio (PU/CU) for TTP versus HUS. Patients/Methods: In a retrospective study, in association with the “French Score” (FS) (platelets < 30 G/L and serum creatinine level < 200 µmol/L), we assessed PU/CU for the diagnosis of TTP in patients above the age of 15 with thrombotic microangiopathy (TMA). Patients with a history of kidney disease or with on-going cancer, allograft or pregnancy were excluded from the analysis. Results: Between February 2011 and April 2019, we identified 124 TMA. Fifty-six TMA patients for whom PU/CU were available, including 35 TTP and 21 HUS cases, were considered. Using receiver–operating characteristic curves (ROC), those with a threshold of 1.5 g/g for the PU/CU had a 77% sensitivity (95% CI (63, 94)) and a 90% specificity (95% CI (71, 100)) for TTP diagnosis compared with those having an 80% sensitivity (95% CI (66, 92)) and a 90% specificity (95% CI (76, 100) with a FS of 2. In comparison, a composite score, defined as a FS of 2 or a PU/CU ≤ 1.5 g/g, improved sensitivity to 99.6% (95% CI (93, 100)) for TTP diagnosis and enabled us to reclassify seven false-negative TTP patients. Conclusions: The addition of urinary PU/CU upon admission of patients with TMA is a fast and readily available test that can aid in the differential diagnosis of TTP versus HUS alongside traditional scoring.
- 27 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 648
Open AccessUrine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
Background: Early diagnosis of thrombotic thrombocytopenic purpura (TTP) versus hemolytic and uremic syndrome (HUS) is critical for the prompt initiation of specific therapies. Objective: To evaluate the diagnostic performance of the proteinuria/creatininuria ratio (PU/CU) for TTP versus HUS. Patients/Methods: In a retrospective study, in association with the “French Score” (FS) (platelets < 30 G/L and serum creatinine level < 200 µmol/L), we assessed PU/CU for the diagnosis of TTP in patients above the age of 15 with thrombotic microangiopathy (TMA). Patients with a history of kidney disease or with on-going cancer, allograft or pregnancy were excluded from the analysis. Results: Between February 2011 and April 2019, we identified 124 TMA. Fifty-six TMA patients for whom PU/CU were available, including 35 TTP and 21 HUS cases, were considered. Using receiver–operating characteristic curves (ROC), those with a threshold of 1.5 g/g for the PU/CU had a 77% sensitivity (95% CI (63, 94)) and a 90% specificity (95% CI (71, 100)) for TTP diagnosis compared with those having an 80% sensitivity (95% CI (66, 92)) and a 90% specificity (95% CI (76, 100) with a FS of 2. In comparison, a composite score, defined as a FS of 2 or a PU/CU ≤ 1.5 g/g, improved sensitivity to 99.6% (95% CI (93, 100)) for TTP diagnosis and enabled us to reclassify seven false-negative TTP patients. Conclusions: The addition of urinary PU/CU upon admission of patients with TMA is a fast and readily available test that can aid in the differential diagnosis of TTP versus HUS alongside traditional scoring.
- 12 September 2021
- Published by JLE in Nephrologie & Therapeutique
- Vol. 17 (5) , 380
Réévaluation de l’épidémiologie et des facteurs de risque des infections opportunistes en transplantation rénale
Introduction: Les infections opportunistes (IOs) sont responsables d’une lourde morbi-mortalité après transplantation rénale. L’objectif de l’étude était de réexaminer leur épidémiologie et leur facteurs de risque avec les traitements immunosuppresseurs et prophylactiques actuels. Description: Tous les patients majeurs greffés rénaux dans notre centre de 2004 à 2015 ont été suivis jusqu’en 2017. Les données clinico-biologiques ont été obtenues des dossiers médicaux informatisés. Méthodes: L’incidence et les marqueurs de risque d’IOs ont été déterminés en utilisant des modèles statistiques innovants, à fragilités partagées ou conjointes, particulièrement adaptés aux événements récurrents. Résultats: Sur 1144 patients suivis pendant 5,9 ± 3 ans, 373 (33 %) ont présenté 544 IOs. Les maladies à CMV (213), zonas (99), candidoses oropharyngées (71) et néphropathies à BK-virus (43) représentaient 78 % des IOs (Fig. 1A et B). Le taux d’incidence était 9,5 fois plus élevé au cours des 310 premiers jours post-greffe (34,7 vs 3,6 IOs/100 patients/an ensuite, Fig. 1C). Seules certaines IOs contribuaient à ce risque initial accru alors que d’autres avaient un taux d’incidence constant au cours du temps (Fig. 1D). En analyse multivariée, les facteurs de risque indépendants étaient l’âge du donneur (RR = 1,2 par tranche de 10 ans p = 3,8 × 10–4), le sérostatus CMV (RR = 1,2, 1,8 et 3,6 pour les patients D-R+, D + R+ et D + R-, p < 10–12) et une lymphocytose abaissé (RR = 1,05 par diminution de 0,1 G/L de la lymphocytose, p = 1,2 × 10–5). Faire une IO était un marqueur de fragilité avec un risque accru d’IOs ultérieures (p < 10–16) mais aussi de mort rénale (p = 1,4 × 10–3). Conclusion: La première année après greffe rénale est à très haut risque d’IOs, mais ce risque précoce est dominé par le CMV. À l’inverse, il existe un surrisque constant de faire un zona, une infection fongique invasive ou parasitaire. La survenue d’IOs prédispose à d’autres IOs et à la mort rénale, et pourrait être intégrée dans des outils de prédiction dynamique de ces événements.
- 12 September 2021
- Published by JLE in Nephrologie & Therapeutique
- Vol. 17 (5) , 380
Réévaluation de l’épidémiologie et des facteurs de risque des infections opportunistes en transplantation rénale
Introduction: Les infections opportunistes (IOs) sont responsables d’une lourde morbi-mortalité après transplantation rénale. L’objectif de l’étude était de réexaminer leur épidémiologie et leur facteurs de risque avec les traitements immunosuppresseurs et prophylactiques actuels. Description: Tous les patients majeurs greffés rénaux dans notre centre de 2004 à 2015 ont été suivis jusqu’en 2017. Les données clinico-biologiques ont été obtenues des dossiers médicaux informatisés. Méthodes: L’incidence et les marqueurs de risque d’IOs ont été déterminés en utilisant des modèles statistiques innovants, à fragilités partagées ou conjointes, particulièrement adaptés aux événements récurrents. Résultats: Sur 1144 patients suivis pendant 5,9 ± 3 ans, 373 (33 %) ont présenté 544 IOs. Les maladies à CMV (213), zonas (99), candidoses oropharyngées (71) et néphropathies à BK-virus (43) représentaient 78 % des IOs (Fig. 1A et B). Le taux d’incidence était 9,5 fois plus élevé au cours des 310 premiers jours post-greffe (34,7 vs 3,6 IOs/100 patients/an ensuite, Fig. 1C). Seules certaines IOs contribuaient à ce risque initial accru alors que d’autres avaient un taux d’incidence constant au cours du temps (Fig. 1D). En analyse multivariée, les facteurs de risque indépendants étaient l’âge du donneur (RR = 1,2 par tranche de 10 ans p = 3,8 × 10–4), le sérostatus CMV (RR = 1,2, 1,8 et 3,6 pour les patients D-R+, D + R+ et D + R-, p < 10–12) et une lymphocytose abaissé (RR = 1,05 par diminution de 0,1 G/L de la lymphocytose, p = 1,2 × 10–5). Faire une IO était un marqueur de fragilité avec un risque accru d’IOs ultérieures (p < 10–16) mais aussi de mort rénale (p = 1,4 × 10–3). Conclusion: La première année après greffe rénale est à très haut risque d’IOs, mais ce risque précoce est dominé par le CMV. À l’inverse, il existe un surrisque constant de faire un zona, une infection fongique invasive ou parasitaire. La survenue d’IOs prédispose à d’autres IOs et à la mort rénale, et pourrait être intégrée dans des outils de prédiction dynamique de ces événements.
- 1 February 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 199, 105829
Spatial mechanistic modeling for prediction of the growth of asymptomatic meningiomas
- 1 February 2021
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 199, 105829
Spatial mechanistic modeling for prediction of the growth of asymptomatic meningiomas
- 18 October 2019
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (11) , 1597-1604
Estimated Glomerular Filtration Rate Decline and Incident Frailty in Older Adults
Background and objectives: Low eGFR is known to be associated with frailty, but the association between the longitudinal decline of eGFR and incident frailty in older persons remains to be determined. The objective of this study was to investigate whether a fast decline on eGFR would be associated with incident frailty. Design, setting, participants, & measurements: Community dwellers, aged ≥70, were included in this secondary analysis of the 5-year Multidomain Alzheimer Preventive Trial (MAPT). eGFR was calculated using CKD–Epidemiology Collaboration equation at baseline and at 6, 12, and 24 months. The lowest quartile of eGFR slope (−4.1 ml/min per 1.73 m2 per yr) defined a fast decline. The frailty phenotype (unintentional weight loss, exhaustion, low physical activity, slow gait, low handgrip strength assessed with a 0–5 score, where higher is worse; a score ≥3 defines frailty) was assessed at baseline, 6, 12, 24, 36, 48, and 60 months. Cox models were used to test the association between fast eGFR decline and incident frailty. Results: A total of 833 participants were frail neither at baseline nor at 2 years and had appropriate follow-up data. Median (IQR) baseline eGFR was 73 (61–84) ml/min per 1.73 m2. Frailty occurred in 95 (11%) participants between 24 and 60 months. Among them, 31/207 (15%) had fast eGFR decline between baseline and 24 months, and 64/626 (10%) did not. In a Cox model adjusted for demographic variables, cardiovascular comorbidity, C-reactive protein, and baseline eGFR, a fast eGFR decline was associated with incident frailty (HR 1.67, 95% CI 1.03 to 2.71). Sensitivity analyses provided consistent findings. Conclusions: In community-dwelling older adults with relatively preserved baseline eGFR, a fast eGFR decline is associated with incident frailty.
- 18 October 2019
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 14 (11) , 1597-1604
Estimated Glomerular Filtration Rate Decline and Incident Frailty in Older Adults
Background and objectives: Low eGFR is known to be associated with frailty, but the association between the longitudinal decline of eGFR and incident frailty in older persons remains to be determined. The objective of this study was to investigate whether a fast decline on eGFR would be associated with incident frailty. Design, setting, participants, & measurements: Community dwellers, aged ≥70, were included in this secondary analysis of the 5-year Multidomain Alzheimer Preventive Trial (MAPT). eGFR was calculated using CKD–Epidemiology Collaboration equation at baseline and at 6, 12, and 24 months. The lowest quartile of eGFR slope (−4.1 ml/min per 1.73 m2 per yr) defined a fast decline. The frailty phenotype (unintentional weight loss, exhaustion, low physical activity, slow gait, low handgrip strength assessed with a 0–5 score, where higher is worse; a score ≥3 defines frailty) was assessed at baseline, 6, 12, 24, 36, 48, and 60 months. Cox models were used to test the association between fast eGFR decline and incident frailty. Results: A total of 833 participants were frail neither at baseline nor at 2 years and had appropriate follow-up data. Median (IQR) baseline eGFR was 73 (61–84) ml/min per 1.73 m2. Frailty occurred in 95 (11%) participants between 24 and 60 months. Among them, 31/207 (15%) had fast eGFR decline between baseline and 24 months, and 64/626 (10%) did not. In a Cox model adjusted for demographic variables, cardiovascular comorbidity, C-reactive protein, and baseline eGFR, a fast eGFR decline was associated with incident frailty (HR 1.67, 95% CI 1.03 to 2.71). Sensitivity analyses provided consistent findings. Conclusions: In community-dwelling older adults with relatively preserved baseline eGFR, a fast eGFR decline is associated with incident frailty.